| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/05/2004 | US20040023878 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular |
| 02/05/2004 | US20040023855 Biologic modulations with nanoparticles |
| 02/05/2004 | US20040023849 Surfactants useful for enhancing the electrical conduction of electrodes attached to the surface of a patient. The surfactants are also useful in transport of materials in and out of the body of a patient (animal or human) and in the |
| 02/05/2004 | US20040023847 (5-(2-Hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 02/05/2004 | US20040023842 Methods for their preparation and use, are disclosed in which the biocompatible crosslinked polymers are formed from water soluble precursors having electrophilic and nucleophilic groups capable of reacting and crosslinking in situ for seals |
| 02/05/2004 | US20040023393 Forming negatively-charged zwitterionic and/or neutral complexes for delivering genetic material into cells; reverse micelles |
| 02/05/2004 | US20040023204 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/05/2004 | US20040023028 Blend, cross-linkable poly(propylene fumarate) for immobilization and controlled drug delivery |
| 02/05/2004 | US20040022972 Consumable container |
| 02/05/2004 | US20040022939 Accelerating a liquid stream and vibrating the stream to form particles; useful for biomedical applications for humans and animals including controlled-release drug delivery systems. |
| 02/05/2004 | US20040022938 Method of coating fine particles with lipid film |
| 02/05/2004 | US20040022872 Antacid and laxative tablets |
| 02/05/2004 | US20040022868 Free of added persulfates. |
| 02/05/2004 | US20040022866 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine |
| 02/05/2004 | US20040022864 Methods of delivering therapeutic agents |
| 02/05/2004 | US20040022862 Precipitating organic compounds in an aqueous medium to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter its lattice structure |
| 02/05/2004 | US20040022861 Protein or peptide particle; more uniform distribution of particle sizes, smaller particles, particles with increased porosity, more intimate mixing of the particle components and greater surface area |
| 02/05/2004 | US20040022859 Having a solvent with a miscibility in water of less than or equal to 7 wt. % at 25 degrees C., to plasticize the polymer and form a gel therewith; improved shear thinning behavior and reduced injection force |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040022855 Cored tablets comprising amoxicillin and clavulanate |
| 02/05/2004 | US20040022854 Oral administration of proton pump inhibitor |
| 02/05/2004 | US20040022853 Polymer-based, sustained release drug delivery system |
| 02/05/2004 | US20040022852 Chemical delivery device |
| 02/05/2004 | US20040022851 Sustained release of guaifenesin combination drugs |
| 02/05/2004 | US20040022850 Modified release formulation |
| 02/05/2004 | US20040022849 Oral pharmaceutical composition with controlled release and prolonged absorption |
| 02/05/2004 | US20040022848 Does not cause adhesion of granules thereof onto a granulation apparatus during granulation and which prevents caking of the granules |
| 02/05/2004 | US20040022847 Delivering by oral ingestion a nutritional supplement consisting of an hyaluronic acid, or a salt or digest thereof, and a food acceptable carrier for relieving joint pain or other discomforts associated with joint disorders |
| 02/05/2004 | US20040022846 Reduced side-effects |
| 02/05/2004 | US20040022845 Oral formulations for localized colonic release and the method of preparation thereof |
| 02/05/2004 | US20040022843 Lipophilic electrophoretic probes |
| 02/05/2004 | US20040022841 Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof |
| 02/05/2004 | US20040022840 Nanoparticle vaccines |
| 02/05/2004 | US20040022838 Regulation of cell proliferation and differentiation using topically applied peptides |
| 02/05/2004 | US20040022837 Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
| 02/05/2004 | US20040022836 Transdermal therapeutic systems comprising photosensitive active substances |
| 02/05/2004 | US20040022835 Transdermal composition of an antivomiting agent |
| 02/05/2004 | US20040022834 Pharmaceutical oxan preparation |
| 02/05/2004 | US20040022833 Child's wiping system |
| 02/05/2004 | US20040022831 For therapy of mycosis of the nail |
| 02/05/2004 | US20040022824 For delivery of one or more drugs to a body of a patient via a medical device placed in the patient's body; medical device |
| 02/05/2004 | US20040022820 To solubilize pharmaceutical actives difficult for the body to absorb |
| 02/05/2004 | US20040022819 Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
| 02/05/2004 | US20040022817 Non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered |
| 02/05/2004 | US20040022814 For use in vaccine |
| 02/05/2004 | US20040022808 Use of a split enveloped virus preparation which is not a split influenza virus preparation in the manufacture of vaccine formulation for itranasal delivery |
| 02/05/2004 | US20040022806 Oral preparation containing seaweed for reduction of plaque and calculus |
| 02/05/2004 | US20040022798 Can stored for several years, and which are ready to use after thawing |
| 02/05/2004 | US20040022780 Topically applying to the skin of a mammal an effective amount of topically active formulation comprising a first topically active agent for therapy |
| 02/05/2004 | US20040022755 For coating substrates, such as tablets and capsules |
| 02/05/2004 | US20040022741 Topical steroid spray |
| 02/05/2004 | US20040022740 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 02/05/2004 | US20040022739 Nasal spray formulation and method |
| 02/05/2004 | US20040022726 Administering via urethra multispecific antibody; allowing antibody to localize at the site of bladder cancer, allowing free antibody to clear from patient; administering carrier conjugated to one or more therapeutic agents |
| 02/05/2004 | US20040020173 Low temperature anodic bonding method using focused energy for assembly of micromachined systems |
| 02/05/2004 | DE10233738A1 Stable suspensions of carotenoids, retinoids and/or unsaturated fatty acids, useful as additives in food, feed, pharmaceutical or cosmetic preparations, containing insoluble ascorbate salt particles as antioxidant |
| 02/05/2004 | DE10233632A1 Formulierungen von Phenylalanin-Derivaten Formulations of phenylalanine derivatives |
| 02/05/2004 | DE10232595A1 Lichtschutzmittel Light stabilizers |
| 02/05/2004 | CA2506963A1 Implantable or insertable medical devices for controlled drug delivery |
| 02/05/2004 | CA2494400A1 Injectable multimodal polymer depot compositions and uses thereof |
| 02/05/2004 | CA2494358A1 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | CA2494233A1 Formulations and dosage forms for controlled delivery of topiramate |
| 02/05/2004 | CA2494198A1 Implantable mems medicine delivery system |
| 02/05/2004 | CA2494069A1 Pellicle-resistant gelatin capsule |
| 02/05/2004 | CA2493980A1 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | CA2493761A1 Compositions comprising hmg-coa reductase inhibitor |
| 02/05/2004 | CA2493671A1 Lipophilic electrophoretic probes |
| 02/05/2004 | CA2493629A1 Pramipexole once-daily dosage form |
| 02/05/2004 | CA2493581A1 Ophthalmologic irrigation solutions and method |
| 02/05/2004 | CA2493179A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
| 02/05/2004 | CA2493128A1 Crystalline .beta.2 adrenergic receptor agonist |
| 02/05/2004 | CA2493076A1 Composition comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent |
| 02/05/2004 | CA2492490A1 Chinese herbal medical composition in the form of jelly |
| 02/05/2004 | CA2492424A1 Sustained-release tablet comprising reboxetine |
| 02/05/2004 | CA2491078A1 Percutaneous and perungual delivery system |
| 02/05/2004 | CA2488860A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
| 02/04/2004 | EP1386935A1 Dual stimuli-responsive hydrogels and their synthetic methods |
| 02/04/2004 | EP1386905A1 Stable solution of reduced coenzyme q |
| 02/04/2004 | EP1386669A1 Aerosol product |
| 02/04/2004 | EP1386614A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
| 02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
| 02/04/2004 | EP1386606A1 Stable high− concentration injection containing pyrazolone derivative |
| 02/04/2004 | EP1386605A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/04/2004 | EP1386604A1 Improved transdermal delivery system |
| 02/04/2004 | EP1386600A1 Composition gelled with a dextrin ester |
| 02/04/2004 | EP1386251A2 Method and apparatus for compounding individualized dosage forms |
| 02/04/2004 | EP1385948A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 02/04/2004 | EP1385947A1 Compositions and methods to control bleeding |
| 02/04/2004 | EP1385935A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 02/04/2004 | EP1385888A1 Method for producing low-viscous, aqueous cellulose ether solutions |
| 02/04/2004 | EP1385613A2 Focused acoustic energy in the generation of solid particles |
| 02/04/2004 | EP1385562A1 Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve |
| 02/04/2004 | EP1385552A1 Oral delivery method and composition for solid medications or dietary supplements |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385543A1 Human medical treatment by application of immunoglobulin a |
| 02/04/2004 | EP1385530A1 Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption |
| 02/04/2004 | EP1385528A2 Disinfecting and solubilizing steroid compositions |
| 02/04/2004 | EP1385521A2 Pharmaceutical composition containing pde v inhibitors and surfactants |
| 02/04/2004 | EP1385519A2 Compounds for treating inflammatory diseases |
| 02/04/2004 | EP1385511A1 Composition comprising antifungal agents for treating vulvovaginitis and vaginosis |